HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HD Biosciences (China) Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10877
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others. It offers services including hit identification and lead discovery, therapeutic antibody discovery, in vivo pharmacology, technology around target validation, plate-based pharmacology, and other research and development services. HDB offers services in the therapeutic areas of oncology, metabolic diseases, CNS diseases, inflammation and immunology, liver diseases, and infectious diseases. The organization also provides custom peptides synthesis services, kinase assay, bio analysis, ion channels, transporters and high-throughput screening format using plate based platforms. It has operations in China and the US. HDB is headquartered in Pudong, China.

HD Biosciences (China) Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
HD Biosciences Enters into Co-development Agreement with ABBIOSCI 10
HD Biosciences Enters into Co-Development Agreement with MIIR and Joan C. Edwards School of Medicine 11
Acquisition 12
WuXi AppTec Acquires HD Biosciences 12
HD Biosciences (China) Co Ltd – Key Competitors 13
HD Biosciences (China) Co Ltd – Key Employees 14
HD Biosciences (China) Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HD Biosciences (China) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HD Biosciences Enters into Co-development Agreement with ABBIOSCI 10
HD Biosciences Enters into Co-Development Agreement with MIIR and Joan C. Edwards School of Medicine 11
WuXi AppTec Acquires HD Biosciences 12
HD Biosciences (China) Co Ltd, Key Competitors 13
HD Biosciences (China) Co Ltd, Key Employees 14
HD Biosciences (China) Co Ltd, Other Locations 15

List of Figures
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Charcot-Marie-Tooth Association:製薬・医療:M&Aディール及び事業提携情報
    Summary Charcot-Marie-Tooth Association (CMTA) is a healthcare service provider that offers healthcare services to patients suffering from charcot marie tooth disease. The association provides services such as public education, patient support, and research promotion. It offers services such as orth …
  • Commonwealth Scientific and Industrial Research Organisation:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Mount Gibson Iron Ltd:企業の戦略・SWOT・財務情報
    Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report Summary Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Akonni Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • PDF Solutions Inc (PDFS):企業の財務・戦略的SWOT分析
    Summary PDF Solutions Inc (PDF Solutions) is a technology company that offers yield improvement technologies and services for the IC manufacturing process life cycle. The company offers products such as Exensio Control, Exensio Yield, Exensio Test, Exensio Char, Yield Ramp Simulator and Circuit Surf …
  • Limacorporate SpA:医療機器:M&Aディール及び事業提携情報
    Summary Limacorporate SpA (Lima) is a medical device company that develops, manufactures and commercializes reconstructive and fixation orthopaedic solutions. The company offers large joint primary and revision implants, extremities and fixation and promade products. It provides medical devices for …
  • Ana Holdings Inc.:戦略・SWOT・企業財務分析
    Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Aerovironment Inc
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cardiff University-製薬・医療分野:企業M&A・提携分析
    Summary Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of enginee …
  • GeoPark Ltd (GPRK):石油・ガス:M&Aディール及び事業提携情報
    Summary GeoPark Ltd (GeoPark) is an oil and gas exploration and production company that explores, develops and produces upstream oil and gas in Latin America. The company operates various blocks such as Colombia blocks, Chile blocks, Brazil blocks, Peru blocks and Argentina blocks. Its Colombia bloc …
  • CenterPoint Energy Inc (CNP):電力:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Hillenbrand, Inc.:企業の戦略・SWOT・財務情報
    Hillenbrand, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hillenbrand, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NetEnt AB (NET B):企業の財務・戦略的SWOT分析
    Summary NetEnt AB (NetEnt), formerly Net Entertainment NE AB, is a gaming solution provider. The company offers netent live, pooled jackpots, branded games, casinomodule, back office, touch, live casino and extend. It provides services such as business intelligence, regulated markets, iGaming media …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務分析
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Temasek Holdings (Private) Ltd:企業のM&A・事業提携・投資動向
    Temasek Holdings (Private) Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Temasek Holdings (Private) Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • AMVIG Holdings Ltd.:企業の戦略・SWOT・財務情報
    AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Johnson Matthey Plc (JMAT):電力:M&Aディール及び事業提携情報
    Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fab …
  • Forestar Group Inc:企業の戦略・SWOT・財務分析
    Forestar Group Inc - Strategy, SWOT and Corporate Finance Report Summary Forestar Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Syneron Medical Ltd-医療機器分野:企業M&A・提携分析
    Summary Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆